336972
Emergency contraception in post-revolution Tunisia: A national study of pharmacy access
Methods: In 2012-2014 we conducted a multi-methods study of the availability, accessibility, and acceptability of ECPs in Tunisia. The study included interviews with representatives from 208 retail pharmacies in eight Tunisian governorates. Our French and Arabic interviews focused on current stock and sales patterns, provision practices at the pharmacy, and client profiles. We analyzed our data using descriptive statistics and for content and themes.
Results: ECPs were in-stock in at least one pharmacy in almost all of our study communities and ECP knowledge among pharmacists was excellent. However, there were several pharmacists – all in the center and south – that believed that ECPs require a prescription. Although a few pharmacies, as a matter of policy, will not provide ECPs to unmarried women, most pharmacists reported the provision of ECPs to any woman in need was a professional duty. Men constitute a significant portion of ECP clients.
Discussion: Availability of ECPs in the post-revolution period remains excellent. However, continuing pharmacist education efforts and supporting youth-friendly reproductive health initiatives appears warranted.
Learning Areas:
Public health or related laws, regulations, standards, or guidelinesPublic health or related organizational policy, standards, or other guidelines
Public health or related research
Social and behavioral sciences
Learning Objectives:
Explain the history of ECPs in Tunisia
Describe the role of pharmacists in ECP access
Identify avenues for improving service delivery
Keyword(s): Contraception, International Health
Qualified on the content I am responsible for because: I am the Chair of the PRSH section and hold an Endowed Chair in Women's Health Research at the University of Ottawa.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.